Domain Therapeutics

is a France-based biopharmaceutical company that researches and develops GPCR-mediated immunotherapies for the treatment of cancer...
Read more
Domain Therapeutics CEO: Sean A. MacDonald

CEO

Sean A. MacDonald

CEO Approval Rating

90/100

2008

PrivateIndependent Company

2834 NAICS listing
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$52.8M
Acquisitions
2
Investments
1

Domain Therapeutics Competitors

1OSE Immunotherapeutics
2Innate Pharma
3Cellectis
4Verastem Oncology
5Pharmacyclics
6TG Therapeutics
7Arena

Trending Companies